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Methods for Detecting PER2:LUCIFERASE
Bioluminescence Rhythms in Freely Moving Mice
Blanca Martin-Burgos* , Wanqi Wang* , Ivana William* , Selma Tir* , Innus Mohammad†,
Reja Javed*, Stormi Smith*, Yilin Cui* , Jessica Arzavala*, Dalilah Mora*, Ciearra B. Smith‡,§,
Vincent van der Vinne§,||, Penny C. Molyneux*, Stephen C. Miller†, David R. Weaver‡,§ ,
Tanya L. Leise¶ , and Mary E. Harrington*,1
*
Neuroscience Program, Smith College, Northampton, Massachusetts, †Department of Biochemistry and
Molecular Pharmacology, University of Massachusetts Chan Medical School, Worcester, Massachusetts,
‡
Graduate Program in Neuroscience, University of Massachusetts Chan Medical School, Worcester,
Massachusetts, §Department of Neurobiology, University of Massachusetts Chan Medical School, Worcester,
Massachusetts, ||Department of Biology, Williams College, Williamstown, Massachusetts, and ¶Department
of Mathematics & Statistics, Amherst College, Amherst, Massachusetts
Abstract Circadian rhythms are driven by daily oscillations of gene expression. An important tool for studying cellular and tissue circadian rhythms is
the use of a gene reporter, such as bioluminescence from the reporter gene
luciferase controlled by a rhythmically expressed gene of interest. Here we
describe methods that allow measurement of circadian bioluminescence from
a freely moving mouse housed in a standard cage. Using a LumiCycle In Vivo
(Actimetrics), we determined conditions that allow detection of circadian
rhythms of bioluminescence from the PER2 reporter, PER2::LUC, in freely
behaving mice. The LumiCycle In Vivo applies a background subtraction that
corrects for effects of room temperature on photomultiplier tube (PMT) output. We tested delivery of d-luciferin via a subcutaneous minipump and in
the drinking water. We demonstrate spikes in bioluminescence associated
with drinking bouts. Further, we demonstrate that a synthetic luciferase substrate, CycLuc1, can support circadian rhythms of bioluminescence, even
when delivered at a lower concentration than d-luciferin, and can support
longer-term studies. A small difference in phase of the PER2::LUC bioluminescence rhythms, with females phase leading males, can be detected with
this technique. We share our analysis scripts and suggestions for further
improvements in this method. This approach will be straightforward to apply
to mice with tissue-specific reporters, allowing insights into responses of specific peripheral clocks to perturbations such as environmental or pharmacological manipulations.
Keywords bioluminescence, circadian, CycLuc1, in vivo, PERIOD2, peripheral oscillators, reporter gene, luciferase
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Circadian rhythms arise from cycles of gene
expression that occur in cells throughout the body.
These cellular rhythms can be observed using a transgenic mouse with a circadian clock promoter or protein, linked to a reporter that generates signal as
fluorescence or bioluminescence. The mPer2Luc mouse,
created in the laboratory of Joseph Takahashi (Yoo
et al., 2004), has allowed many major advances in our
understanding of circadian biology, largely through
studies conducted using explant culture techniques.
The transgene in this animal produces a fusion protein linking PERIOD2 (PER2) with firefly luciferase.
Firefly luciferase, when provided with a substrate
such as d-luciferin, will emit light (bioluminescence;
for an overview, see Shimomura, 2012).
Bioluminescence has several advantages compared to fluorescence for long-term studies, including low phototoxicity and very low background
noise (Troy et al., 2004). Studies of bioluminescence
in tissue explants can reveal cellular activity, but can
often only assess isolated tissues outside their natural physiochemical environment. In addition, in
some circumstances, the time of dissection for tissue
preparation can reset the phase of cellular circadian
clocks (Noguchi et al., 2020; Leise et al., 2020), thereby
limiting the comparison of circadian phase recorded
in vitro to the preceding phase in vivo. More complex interactions between tissues are best studied
within a living intact animal.
To address these challenges, we and others have
explored methods for recording bioluminescence in
vivo. One approach is to use anesthetized animals,
detecting bioluminescence using a camera-based system. This approach has been used to assess the phase
of peripheral tissue rhythms (Tahara et al., 2012) but
has the unavoidable disadvantage of repeated general anesthesia. Anesthesia has been shown to disrupt circadian rhythms in body temperature and in
rest/activity cycles, and may inhibit photic entrainment of the circadian clock (Poulsen et al., 2018). The
method also requires bioluminescence assessments at
six to nine time points, each requiring experimenter
presence, over 24-36 h for a single circadian phase
assessment. A second approach is to record bioluminescence from freely behaving mice, detecting light
emission using sensitive photomultiplier tubes
(PMTs). Here we build on the pioneering work from
the Schibler laboratory (Saini et al., 2013) that demonstrated the feasibility of recording light emitted from
a mouse in a specialized housing chamber, the “RT
Biolumicorder” (LESA Technology). In their work,
rhythmic signal was detected from bioluminescent
reporters directed to the liver using viral transduction in hairless mice, as well as in mPer2Luc C57BL/6
mice with fur removed from the dorsal region. In
addition to establishing feasibility of the method, the

system was used to control food availability and provide lighting regimens for studies of entrainment.
Some areas of further research are to develop a system that allows housing in standard cages, to test
nonsurgical methods for delivery of d-luciferin, and
to test synthetic luciferins that may offer increased
sensitivity (Evans et al., 2014).
We present here results from studies of
PER2::LUC bioluminescence in C57BL/6J mice
(both black and albino), recorded in standard housing cages within the “LumiCycle In Vivo” system
(designed for these experiments by Actimetrics
Inc.). We compare two methods of delivery for the
substrate: delivery through drinking water and
using subcutaneous osmotic minipumps. In addition, we assessed whether a synthetic luciferin,
CycLuc1 (Evans et al., 2014; Reddy et al., 2010), can
offer advantages as a substrate in these experiments. In the course of this work, we encountered
several methodological challenges and address
here how they may be overcome. We believe that
these methods could be widely adopted and could
also be improved through further innovation.
Ultimately, we predict the field of circadian biology
will benefit from expanded use of unrestrained, in
vivo, bioluminescence recordings.

Methods
The LumiCycle In Vivo
Bioluminescence was measured using the
“LumiCycle In Vivo” system, designed by David
Ferster (Actimetrics). The system can record luminescent emissions from freely behaving animals housed
in a standard mouse cage placed within a light-tight
chamber (Suppl. Fig. S1).
Each unit contained two PMTs (Hamamatsu
H8259-01, selected for low dark counts and positioned for sensitivity across the cage area), and was
equipped with programmable LED lights, and a
high-capacity internal fan that provided 15 air
changes per hour. A simple sum of the two PMT
counts (corrected for dark counts as described below)
was used as the signal (Suppl. Fig. S2). A programmable shutter periodically blocked the PMTs and
allowed the collection of dark counts. In the studies
reported here, dark counts were measured every 15
min by closing the shutter for 1 min. Each dark count
value was subtracted from the counts recorded during the subsequent 14 min to obtain the backgroundcorrected count values. This was necessary to remove
the effect of external temperature fluctuations on
PMT noise. Temperature alters the PMT dark counts,
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and employed either FVB/NJ mice purchased from
Jackson Laboratories and given intravenous injection
of AAV9-CMV-WTluc2 as previously described
(Mofford et al., 2015) or, in separate studies, mice
with a single copy of the PER2::LucSV allele (Welsh
et al., 2004; Yoo et al., 2017). The latter mice are
referred to as mPer2LucSV/+ to distinguish them from
the homozygous mice used elsewhere.
Studies of albino C57BL/6J reporter mice used
mice bred at the University of Massachusetts Medical
School, and tested at Smith College. These mice were
albino C57BL/6J background (JAX #000058), and
carried one or two reporter alleles (mPer2LucSV/+ or
mPer2LucSV/LucSV). Both male and female mice were
used.
All animal studies were approved by the
Institutional Animal Care and Use Committees of the
appropriate institution.
Figure 1. Fluctuations in room temperature impact photomultiplier (PMT) output, as shown in a recording from an empty
recording chamber with no animal present over 5 days with
extreme temperature variations. This is corrected by subtracting
dark counts in the LumiCycle In Vivo (Actimetrics) as shown in
(c). (a) Raw photomultiplier tube output (black line) tracks room
temperature (shown in blue dotted line) prior to adding the capability for dark count subtraction. (b) Same data as in (a) plotted
to demonstrate the tight correlation. (c) Following installation of
software to collect background readings every 15 min and subtract these from prior PMT outputs, effects of room temperature
fluctuations are corrected (compare [c] to [b]). Abbreviation:
PMT = photomultiplier tube.

but not PMT sensitivity (https://www.hamamatsu.
com/resources/pdf/etd/PMT_handbook_v4E.pdf).
Prior to this correction, we observed noise highly correlated to temperature (R2 = 0.96; see Figure 1) and
less so with humidity (R2 = 0.30). One degree Celsius
of chamber ambient temperature increase was associated with an increase of circa 35 counts/s. A chamber
history for all recording units was collected, to monitor temperature, relative humidity, and light measures within each unit. Animal welfare was checked
once a day at varied times using an infrared viewer
(Carson OPMOD DNV 1.0), or goggles (Pulsar Edge
Night Vision Goggles PL75095).
Animals
For initial studies conducted at Smith College,
homozygous mPer2Luc/Luc male and female mice animals were bred in-house from founders obtained
from Jackson Labs (JAX #006852) (Yoo et al., 2004).
Mice ranged in age from 4.5 to 8 months. We chose
homozygous mice to maximize luciferase expression.
Mouse imaging studies were conducted at the
University of Massachusetts Chan Medical School,

Delivery of Substrates by Subcutaneous Osmotic
Minipump
A delivery method that can provide continuous
dosing is to use a subcutaneous osmotic minipump.
Prior studies have reported mixed results with similar methods (Gross et al., 2007; Saini et al., 2013;
Hamada et al., 2016). We determined that 100 mM
was close to the limit of solubility for d-luciferin in
our conditions and therefore tested this concentration
in both 7- and 14-day Alzet osmotic minipumps
(models 1007D and 1002, respectively) to vary the
rate of delivery (0.5 and 0.25 uL/h). A total of 100mM d-luciferin was prepared in sterile 0.1-M sodium
phosphate buffer (PB) and mixed on an Eppendorf
ThermoMixer (Thermo Fisher Scientific, Waltham,
MA) at 37 °C for 2 min at 1500 r/min. Following surgery to implant an osmotic minipump subcutaneously, we allowed 3-days recovery before initiating
bioluminescence recording (see Suppl. Methods for
details).
A synthetic luciferin, CycLuc1, has been shown in
prior studies to offer better distribution throughout
the body and greater light emissions at lower concentrations (Evans et al., 2014). We tested whether this
synthetic luciferin could provide comparable or
superior results to d-luciferin when delivered via an
osmotic pump. CycLuc1 (produced in the lab of Dr.
Stephen Miller, University of Massachusetts Chan
Medical School, Worcester, MA) was prepared in a
5-mM solution in sterile 0.1-M phosphate-buffered
saline (PBS) and was mixed as for d-luciferin. Both
7- and 14-day pumps were tested.
In the initial experiment, the bioluminescence data
were collected until day 9 for 7-day pumps and until
day 11-13 for 14-day pumps. After removal, any
residual volume remaining in pumps was measured
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to check against the expected rate of delivery, and any
changes in the appearance of the solution were noted.
Data files were truncated if necessary to remove measures taken after calculated pump depletion. In the
subsequent experiment, each animal received only
one pump implant, a 14-day pump with CycLuc1.
Each animal underwent two minipump trials
using the procedures described above. The two pump
implantation surgeries were separated by 28 days
and within each group of surgeries, pump volumes
were selected in a counterbalanced design. Each animal received the same substrate on both occasions,
with only the pump type (7 or 14 day) differing.
Delivery of Luciferin by Drinking Water
A technically simple manner of substrate delivery
is to provide the compound in the drinking water. A
prior study suggested this approach of substrate
delivery would be feasible (Hiler et al., 2006). This
approach depends on the availability of a reasonably
inexpensive substrate in appropriate amounts, solubility, acceptability by the mouse, and low toxicity.
For our initial experiments, d-luciferin, potassium
salt (LUCK-1G, GoldBio, St Louis, MO) was selected.
Major advantages of this approach are the potential
to conduct long-term studies with fresh solutions
provided at regular intervals, and the avoidance of
surgical procedures. A concern with administration
of substrate in the drinking water is the possibility
that the rhythmic behavior of drinking would lead
to rhythmicity in substrate ingestion and availability, thus producing bioluminescence rhythms that
reflect drinking behavior rather than reporter gene
expression.
To study dose response to d-luciferin through
drinking and reversibility, each mouse was tested for
approximately 3 days at each concentration. We
tested 10, 0, 1, and 5 mM of d-luciferin, in that order.
Solutions were made by dissolving powdered d-luciferin in water in 50-mL conical tubes, vortexing 1-2
min to dissolve particulate and then protected from
light. Experiments were thereafter conducted in constant darkness. Drinking was monitored by measuring residual volume and all doses were equally
tolerated by the mice tested. An additional 3-day
experiment with 0-mM d-luciferin was conducted 5
weeks later, to test baseline levels when it was certain
that no substrate remained within the animal after
prior exposure. On the first day of this experiment as
well as immediately prior to the recording conducted
5 weeks later, animals were anesthetized briefly (circa
5 min) in an induction chamber at 3% isoflurane followed by placement in a nose cone to allow shaving
of back and abdomen (see Suppl. Fig. S3). Animals
were put into the LumiCycle In Vivo unit at the end

of the light portion of the 12:12 LD cycle and were
thereafter recorded in constant darkness. The bottle
of d-luciferin was changed to the new dose every 3
days between CT 6 and CT 11. Mice drank on average
3.9 mL/day.
To determine if mice showed an aversion or preference for the two substrate solutions, we offered 8
mice (4 males) the opportunity to drink from two
tubes presented simultaneously for 48 h in their home
cage while single housed in constant darkness. They
were offered 10 ml in each drinking tube, and after 24
h, the tubes were switched in left-right positions. All
mice were preexposed to the substrate solutions.
Mice were then offered either CycLuc1 or d-luciferin
vs water, in a counterbalanced order, and then all
mice were offered a choice between CycLuc1 and
d-luciferin.
To compare d-luciferin and CycLuc1 delivered in
drinking water, four mice were tested using an ABA
design with 0.1-mM d-luciferin, 0.1-mM CycLuc1,
and a second treatment of 0.1-mM d-luciferin.
Treatments were given for approximately 3 days
each, with approximately 1 day with plain water
available in between each treatment. Mice were given
CycLuc1 for 4 days, due to a circa 1-day equipment
failure during this experimental run. Bioluminescence
was measured in DD using the LumiCycle In Vivo
unit, and volume consumed was monitored by noting initial and final water volumes.
To better understand the correspondence between
behaviors and bioluminescence, we conducted
experiments with mice housed in a cage designed to
allow measures of contact with the drinking tube
(see Suppl. Methods). For these experiments, we
delivered CycLuc1 (0.1 mM; MedChemExpress,
Monmouth Junction, NJ) or d-luciferin (5 mM) in
the drinking water for up to 9 days in constant darkness using albino Per2LucSV/+ mice.
Assessment of the Source of Bioluminescence by
IVIS Imaging
mPer2LucSV/+ mice were allowed ad libitum access
to drinking water containing d-luciferin (2 mM,
n = 10 or 0.1 mM, n = 6) or CycLuc1 (0.1 mM, n =
10) for at least 12 h before study. Another group of
animals (n = 7) had water available and received
d-luciferin by injection (0.1 mL of 10 mM, ip).
Separately, we examined results from mice both
while intact and also while surgically anesthetized
with ketamine/xylazine and the abdomen opened to
reveal signal source more clearly, using mice either
administered d-luciferin ip (0.1 mL of 10 mM, n = 3),
d-luciferin in the drinking water (2 mM, n = 5),
CycLuc1 in the drinking water (0.1 mM, n = 5), or
CycLuc1 by acute oral administration (0.05 mM [in
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50% apple juice]), n = 2. Animals were studied at
clock times at which elevated bioluminescence was
expected based on our previous studies (ZT15-21,
van der Vinne et al., 2018). Mice were anesthetized
with isoflurane, as well as ketamine/xylazine when
dissected, removed briefly to be shaved, and images
were captured of ventral and dorsal views using
Living Image software on an In Vivo Imaging System
(IVIS-100, Caliper, now Perkin Elmer) in the UMass
Chan Medical School Small Animal Imaging Core
Facility. Quantitative analysis of bioluminescence
was performed using Living Image 4.4 software.
Data Analysis
All data were analyzed using RStudio, with the
exception of the Bayesian MCMC analysis, which
was run in MATLAB. Data files and R code are
posted on Open Science Framework (https://osf.io/
shgbv/). A discrete wavelet transform (DWT) was
applied to each time series to detrend and to calculate the rhythm phase using the wavelets R package
(https://cran.rstudio.com/web/packages/
wavelets/index.html), as described in Leise and
Harrington (2011) and Leise (2017). We applied the
la12 filter on 15-min median binned data; medians
were used to reduce the effect of large outliers. Data
before the first trough and after the last trough were
discarded to avoid edge effects.
The signal-to-noise ratio (SNR) in decibels was calculated for 2-day windows, starting at the first trough
(dropping most of the first day of recording), as 10
times the log10 of the ratio of the sum of squares of
DWT circadian component D6 to the sum of squares
of all DWT components at least 2 levels below the circadian scale (D1-D4). The level immediately below
circadian (D5) contains an inseparable mix of circadian and noise energy, so was discarded. An SNR
value above 0 indicates the signal is stronger than the
noise (ratio was greater than 1). The SNR does not
statistically test whether there is a significant circadian rhythm present, although a high SNR value
strongly suggests it. A negative SNR value can mean
either a rhythm swamped by noise or no rhythm
(ratio of signal-to-noise energy was less than 1).
The circadian energy is the sum of squares of the
DWT circadian component D6 divided by the sum of
squares of all DWT components D1-D6, yielding the
proportion of total energy that is at the circadian
scale, for the same window as the SNR. This proportion does not indicate whether there is a significant
circadian rhythm present.
As a measure of uncertainty in whether the period
can be determined from the data, we ran a Bayesian
statistical analysis via MCMC sinusoid fitting, as
described in Cohen et al. (2012), for 4-day windows,

dropping the first 24 h of recording. The procedure
generates a distribution of period estimates, where
the 95% credible interval (CI) is the interval of most
likely period values. A mean period estimate can also
be obtained from this distribution. The CI provides
evidence for whether the period of a time series can
be reliably measured. The wider the CI, the less credible it is that the time series has a measurable circadian period. Only 14-day pump records were used
for this computation, to have sufficient length.
To assess the statistical significance of circadian
rhythms in the data, JTK and Lomb-Scargle q values
(false discovery rate–adjusted p values) were calculated using the MetaCycle R package (Wu et al.,
2016), applied to 3-day windows, dropping the first
24 h of the recording and using 90-min median binning to reduce correlated high-frequency noise and
outliers.
DWT peak times are the peaks in the circadian signal component of the bioluminescence obtained
using the DWT. Time relative to projected lights indicates the DWT peak times in relation to the time of
lights-on (0600) in the colony room where animals
were housed prior to the in vivo bioluminescence
experiments.
Further experimental details are provided in the
Supplementary Methods.

Results
As in many previous reports (Saini et al., 2013; van
der Vinne et al., 2018; Crosby et al., 2019), we were
able to detect circadian rhythms of bioluminescence
in vivo from mice carrying the mPer2Luc transgene
(see Figure 2). Given that the reporter signal arises
from multiple tissues (see below), this suggests that
the tissues we are detecting express rhythms with
some degree of synchrony even during housing in
constant darkness.
We first investigated bioluminescence rhythms in
mice receiving d-luciferin continuously using an
osmotic minipump (Figure 2). A 14-day pump delivers a smaller volume per hour than a 7-day pump
(0.25 uL/h vs 0.5 uL/h, respectively) yet both pumps
are limited to a 100-uL reservoir. We asked if this reservoir, with 100-mM d-luciferin, was able to lead to a
detectable rhythm in bioluminescence, in a small
sample of 4 mice. This experiment also tested the
impact of holding d-luciferin solution at body temperature for up to 11-12 days. Table 1 shows the
results. One animal was noted to have unusually
rapid fur regrowth and showed progressive signal
loss (see Suppl. Fig. S4C). Both rates of d-luciferin
delivery led to detectable circadian rhythms in
bioluminescence.
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Figure 2. Example of bioluminescence data with (a) 14-day
d-luciferin pump (0.25 uL/h of 100-mM d-luciferin; animal
ID IVM82), or (b) 14-day CycLuc1 pump (0.25 uL/h of 5-mM
CycLuc1; animal ID IVM93). Top graph for each example: 15-min
median binned trace with counts/s scale on the left and normalized scale on the right (subtract first percentile then divide by
median, so min is mapped to zero and median mapped to 1;
using first percentile reduces the effect of outliers). Bottom
graph for each example: For the signal-to-noise ratio analysis,
the DWT-calculated circadian component D6 is treated as the
signal and the summed components D1-D4 are treated as the
noise. The data before the first trough and after the last trough
are discarded to avoid edge effects. Raw data in counts/s from
each PMT are shown for these two animals in Supplementary
Figure S2. Abbreviations: DWT = discrete wavelet transform;
PMT = photomultiplier tube.

In addition, we asked if the synthetic luciferase
substrate, CycLuc1, can be effective at concentrations lower than those of d-luciferin, as previously
seen in studies with acute injection of the substrates
(Evans et al., 2014). We tested 5-mM CycLuc1 in 7and 14-day osmotic minipumps, and again we
detected circadian rhythms in bioluminescence
(Figure 2). Traces for all 16 recordings (7- and 14-day
pumps, both substrates) are given in Supplementary
Figure S4.
Table 1 provides a summary of the analysis of the
osmotic minipump data. All but one animal had bioluminescence profiles that were significantly rhythmic according to both JTK and Lomb-Scargle tests.
The exception is the one mouse (#83) with a 14-day

d-luciferin recording mentioned above, for which
hair regrowth was an issue. The Bayesian statistical
analysis supports this assessment, yielding mean
periods near 24 h and reasonable CI widths, given
the shortness of the time series, again with the exception of the single problematic 14-day d-luciferin
recording. The SNR varied, reflecting the highamplitude noise present in many of these recordings;
noise amplitude tended to increase greatly near signal peaks, as shown in Figures 2 and 3. While SNR
values above 2 tend to allow greater precision in
period and phase estimates, the analysis here suggests that even when noise levels are relatively high,
the recordings are statistically rhythmic with measurable period and phase (though keeping in mind the
uncertainty indicated by the Bayesian analysis). The
circadian energy provides an alternative measure to
the SNR for assessing signal strength.
Next, we asked if we could measure rhythmic bioluminescence using delivery of substrate in the
drinking water, and if the signal varied with the concentration of d-luciferin. As shown in Figure 3, we
saw an increased median level of bioluminescence
with increasing concentration of d-luciferin in the
drinking water across the 4 mice tested, but the SNR
was not reliably altered with dose. The 0-mM condition immediately following the 10-mM concentration allowed us to observe the duration of wash-out
(loss of signal following substrate removal). As
shown in Supplementary Figure S5, residual signal
was observed for variable amounts of time after
d-luciferin (10 mM) withdrawal. Notably, an additional 0-mM condition that was not immediately preceded by d-luciferin administration yielded a true
baseline, with low levels of bioluminescence (with
negative SNR and nonsignificant JTK and LombScargle q values). All drinking water bioluminescence
recordings are shown in Supplemental Figure S5.
We then asked if delivery of the synthetic substrate
CycLuc1 in the drinking water would produce robust
bioluminescence signal at lower concentrations of
substrate, as previously reported (Evans et al., 2014).
As shown in Figure 4 and Supplemental Figure S6B,
CycLuc1 treatment (0.1 mM) produced a stronger
(circa 10-20×) bioluminescence signal than the same
concentration of d-luciferin in each of the 4 animals.
We found no consistent difference in the amount mice
drank across conditions (Suppl. Fig. S6A).
Although mice consumed both substrate solutions, when offered a choice, they displayed some
preference (see Figure 5). We used a two-sided paired
t test to compare consumption across the three trials.
We observed no significant difference between
d-luciferin and water—t(7) = 1.1, p = 0.305. There
was not a significant difference between CycLuc1
and water—t(7) = 2.34, p = 0.052—but there was a
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Table 1.

Summary of key measures of rhythms recorded from mice with osmotic pumps delivering substrate.

Sex

Substrate

Pump

Median
bioluminescence

82

M

d-luciferin

83

M

d-luciferin

84

F

d-luciferin

85

F

d-luciferin

90

M

CycLuc1

91

M

CycLuc1

92

F

CycLuc1

93

F

CycLuc1

14-d
7-d
14-d
7-d
14-d
7-d
14-d
7-d
14-d
7-d
14-d
7-d
14-d
7-d
14-d
7-d

62
157
20
72
42
46
22
30
76
140
237
467
92
173
108
106

Peak time
(h)

Time relative
to projected
lights-on (h)

SNR

Circ.
energy

CI
width

Mean
period

JTK
q value

LS
q value

4.0
5.8
1.8
4.3
−1.0
1.8
−0.7
1.8
5.0
1.0
7.5
6.0
0.5
0.3
−0.2
−0.5

22.0
23.8
19.8
22.3
17.0
19.8
17.3
19.8
23.0
19.0
25.5
24.0
18.5
18.3
17.8
17.5

−1.0
−3.2
−9.9
1.0
4.8
1.8
−0.9
4.4
−1.2
1.7
−3.0
−5.0
2.6
5.3
3.1
1.4

0.50
0.36
0.12
0.49
0.76
0.62
0.40
0.63
0.44
0.61
0.38
0.28
0.67
0.80
0.69
0.62

2.3 h
—
NA
—
0.9 h
—
1.4 h
—
1.5 h
—
1.5 h
—
1.2 h
—
0.9 h
—

23.2 h
—
NA
—
24.5 h
—
23.9 h
—
24.0 h
—
24.9 h
—
24.5 h
—
23.6 h
—

0.01
<0.001
0.1
<0.001
<0.001
<0.001
0.002
<0.001
0.002
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001
<0.001

0.062
<0.001
0.262
<0.001
<0.001
<0.001
0.009
<0.001
0.009
<0.001
<0.001
0.002
<0.001
<0.001
<0.001
<0.001

Abbreviations: SNR = signal-to-noise ratio; CI = credible interval. See section “METHODS” for details. Peak time is given in hours with
0 = midnight, using the peak nearest the day 2 mark. Prior housing room LD cycle had lights-on 0600-1800 h. Median bioluminescence
is for the first 3 days of recording. All mice were C57BL/6 background, with black fur. CI width and mean period were not calculated for
7-day pump data (see text).

Figure 3. Example of bioluminescence data with d-luciferin
delivered via drinking water, using a sequence of doses as indicated. Vertical lines indicate when substrate solutions were
changed.

trend for mice to prefer water. Mice preferred d-luciferin to CycLuc1—t(7) = 9.55, p < 0.001.
Results from recordings of bioluminescence from
mice housed in cages that recorded drinking events
demonstrated strong correspondences between
drinking events and bioluminescence spikes (see
Figure 6). These results suggest that delivery of substrate via drinking water includes artifacts associated
with drinking bouts.
Bioluminescent rhythm damping (as seen, e.g., in
Suppl. Fig. S4G) might be attributable to fur
regrowth in these black mice, and/or substrate degradation over time. We incubated aqueous solutions
of d-luciferin and CycLuc1 for stability for multiple

days at body temperature to determine their relative
stability. Prolonged incubation of d-luciferin at 37 °C
resulted in substantial oxidation of d-luciferin to
dehydroluciferin as judged by Liquid chromatography / mass spectrometry (LC/MS) (see Suppl.
Methods). After 14 days, ~50% of the d-luciferin had
oxidized (Figure 7). Some loss of d-luciferin by racemization to l-luciferin is also likely (Nakajima et al.,
2021). Dehydroluciferin is not a luminogenic substrate for firefly luciferase, and is a much more potent
inhibitor than l-luciferin (da Silva and da Silva, 2011).
The ~6-fold decrease in bioluminescent signal
observed when using this solution for in vivo imaging may thus reflect luciferase inhibition by dehydroluciferin as well as a reduction in the d-luciferin dose.
By contrast, no formation of a dehydroluciferin product was noted for CycLuc1 at 37 °C or for either substrate incubated at 4 °C, and the in vivo imaging
results were comparable to a freshly prepared solution (Suppl. Fig. S7).
We tested 7 mice (4 males) with albino background
and 14-day osmotic minipumps containing CycLuc1 (5
mM). Our recordings of bioluminescence and locomotor activity records from these mice housed in constant
darkness are summarized in Table 2. In this small sample, female mice all showed earlier bioluminescence
peaks than males. The signals, although being noisy,
suggest a sex difference in phase, as shown in Figure 8.
This demonstrates that it is possible to detect a circa 4-h
separation in phase with small samples (n = 3-4).
One shortcoming of assessing bioluminescence
rhythms using the LumiCycle In Vivo is that this
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Figure 4. Bioluminescence counts per day were calculated for each treatment by dividing the total sum of counts by the number of
days. Treatments were 0.1-mM d-luciferin, 0.1-mM CycLuc1, and 0.1-mM d-luciferin, and were 3 days in length with a day of plain water
administered between treatments.

Figure 5. Substrate preference test. Amount consumed (ml) by mice according to substrate solution offered (d-luciferin, 5mM; CycLuc1,
0.1 mM). Each graph (a-c) displays a different experiment in which the same 8 mice were given two options of each substrate in 10 ml
over 48 h. Points connected by lines represent the amount consumed by the same mouse.

method does not provide information on the anatomical source of bioluminescence. Previous studies
of PER2::LUC in mice conducted with bioluminescence imaging have identified the kidneys, liver, and
submandibular gland as the primary sources of “signal” from anesthetized mice (Tahara et al., 2012).
Notably, in each of these studies, the substrate was

provided by intraperitoneal injection. Thus, we performed IVIS imaging studies on mice receiving luciferin substrates by drinking. We imaged both
anesthetized intact mice, as well as acutely dissected
mice administered ketamine/xylazine, to assess the
sites of origin of bioluminescence in mPer2LucSV/+
mice receiving substrate in the drinking water. Mice
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Figure 6. Correspondence between drinking bouts and bioluminescence. Albino mice expressing PER2::LUC showed bioluminescence
that often increased following a drinking bout. Although our cages may have missed some drinking bouts, the detected drinking tube
contacts (shown in orange) could be seen to temporally coincide with spikes in bioluminescence, for both substrates, CycLuc1 (a, b) or
d-luciferin (c, d). This was most obvious when data were in smaller time bins (4-min bins, a, c). With larger time bins (30-min bins, b,
d), the daily rhythm in drinking activity more clearly overlays that of bioluminescence.

drinking d-luciferin (2 or 0.1 mM) or CycLuc1 (0.1
mM) had readily detectable bioluminescence signal,
located predominantly in the kidneys, followed by
the liver and other abdominal structures (see Suppl.
Fig. S8). The distribution following acute ip injection
(d-luciferin: 0.1 ml of 10 mM) was similar to that
observed in mice that had d-luciferin provided in the
drinking water for multiple hours before. Signal
from the upper abdomen (ventral view) or from the
area on the dorsal surface corresponding to the
abdomen (dorsal view) contributed over 75% of photons within the region of interest containing the
entire animal. The anatomical pattern of labeling
did not appear related to the treatment group.
Bioluminescence (at much lower levels) was
observed in a variable pattern in extra-abdominal
sites, including hands, feet, mouth, throat (presumably submandibular gland), and where urine leaves
the body (vulva in females, penis in males), and on
the dorsal side, upper back and rump. Mice receiving d-luciferin by injection had a similar distribution,
including the preponderance of labeling coming
from the abdomen in both ventral and dorsal views.
We compared the log of counts from either ventral or

dorsal views across conditions and sex using analysis of variance (ANOVA). We found a significant
effect of treatment in each view—ventral: F(3,25) =
107.21, p < 0.001; dorsal: F(3,20) = 152.2, p < 0.001.
Tukey contrasts showed bioluminescence was greatest in mice receiving d-luciferin by injection (0.1 mL
of 10 mM), followed by CycLuc1 (0.1 mM) and
d-luciferin (2 mM) (no significant statistical difference between these) and finally by d-luciferin (0.1
mM). When considering the ventral view, we saw no
significant effect of sex—F(1,25) = 0.002, p = 0.96—
but for the dorsal views, we found a weak sex effect,
F(1,20) = 4.59, p = 0.0446; signal trended higher in
males. Images from acutely dissected mice confirmed that the kidney was the greatest source for
bioluminescence in these mice (see Suppl. Fig. S9).

Discussion
These studies extend prior work that established
the feasibility of recording gene expression rhythms
in vivo with bioluminescence. We have chosen to
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Figure 7. Evaluation of d-luciferin after incubation at body temperature. Liquid chromatography / mass spectrometry (LC/MS) and in
vivo bioluminescence imaging with d-luciferin incubated in aqueous buffer at 37 °C for 0, 7, or 14 days. FVB/NJ mice received intravenous
injection of AAV9-CMV-WTluc2 as previously described in a method that primarily transduces heart and leg muscles (Mofford et al., 2015)
and images were collected 12 min postinjection (ip) of the d-luciferin solution. Images shown are from one male mouse imaged on different
days, and the 0-day data from this mouse are shown for comparison with the 7- and 14-day data on the lower two histograms.

conduct initial studies with the most widely used animal model for circadian bioluminescence currently
available, the mPer2Luc/Luc mouse with the reporter
PER2::LUC. We used mice with two copies of the
reporter allele to enhance signal output. Thus, success with this animal model likely sets the mark for
the most we can achieve, with less light expected
from animals with bioluminescence directed to specific organs. On the other hand, PER2::LUC may offer
a noisier rhythmic signal than organ-specific reporters because it is reporting from diverse sources of

signal. These diverse sources must be somewhat
coordinated, to detect circadian rhythms at the wholeanimal level as reported here. Prior studies using
measures collected in vivo indicate that the peripheral tissues of the mouse hold similar phase in Per2
mRNA rhythms. For example, using the “CircaDB”
resource and the JTK analysis (http://circadb.
hogeneschlab.org/), we found Per2 mRNA rhythms
peak in the kidney at ZT15 (mean of 2 estimates), distal colon at ZT15.0, and liver at ZT15.4 (mean of 4
estimates). IVIS imaging experiments similarly
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Table 2.

Summary of key measures of rhythms recorded from albino mice with osmotic pumps delivering CycLuc1.

ID

Sex

Median
Peak time
Time relative to
Substrate Pump bioluminescence
(h)
projected lights-on (h)

SNR

Circ.
energy

CI
width

Mean
period

JTK
q value

LS
q value

252
253
255
256
257
262
263

M
M
F
M
M
F
F

CycLuc1
CycLuc1
CycLuc1
CycLuc1
CycLuc1
CycLuc1
CycLuc1

−2.8
−2.6
0.0
0.3
−1.9
2.1
0.3

0.35
0.41
0.52
0.46
0.41
0.61
0.52

1.7 h
1.3 h
1.2 h
1.2 h
1.7 h
1.0 h
1.6 h

26.2
25.4
24.1
23.5
23.7
24.6
26.4

<0.001
<0.001
0.0019
<0.001
0.0137
<0.001
<0.001

0.0019
0.0019
0.0019
0.0019
0.1445
<0.001
<0.001

14-d
14-d
14-d
14-d
14-d
14-d
14-d

323
455
106
103
265
76
46

4.0
4.3
0.8
2.6
4.1
0.0
−3.0

22.0
22.3
18.8
20.6
22.1
18.0
15.0

Abbreviations: SNR = signal-to-noise ratio; CI = credible interval. See section “METHODS” for details. Peak time is given in hours with
0 = midnight, using the peak nearest the day 2 mark. Prior housing room LD cycle had lights-on 0600-1800 h. Median bioluminescence is
for the first 3 days of recording. All mice were C57BL/6 albino background.

Figure 8. Female mice showed earlier peak times beginning on day
2 in darkness when compared to males. This is visible in the raw
(normalized) data shown. Female (n=3)—blue; male (n=4)—red.

demonstrate close correspondence in phase of
rhythms of body organs under control conditions
(e.g., see van der Vinne et al., 2020). This is consistent
with data from reports assessing bioluminescence
rhythms in anesthetized mice by IVIS imaging, in
which rhythms of PER2::LUC bioluminescence were
relatively synchronous across the tissues assessed
(Tahara et al., 2012; van der Vinne et al., 2018). For
example, in one study (van der Vinne et al., 2018),
liver and kidney showed a peak phase of ZT18.
Animals in our experiments showed peaks in the
same range.
Our results indicate that luciferin substrates are
effective for producing detectable bioluminescence
rhythms when delivered either by drinking water or
by osmotic minipump. The possibility that the daily
drinking rhythm altered the phase and/or amplitude
of the bioluminescence rhythm could not be excluded
in this study. Future studies should be conducted
using mice with a circadian reporter with peak
expression at a phase not coincident with the major
time of voluntary water intake.
All in vivo bioluminescence recordings show noise
that is modulated by the time of day. There could be
multiple sources of this noise and our current studies

do not allow us to distinguish between them.
Possibilities include orientation of the mouse body
relative to the photon detectors (PMTs), position of
the mouse within the cage and distance from the
PMTs, variable blood levels of substrate in the mice
drinking substrate solutions, variable absorption and
processing of the substrate, and likely many others.
Despite these sources of noise, we demonstrate analysis techniques that allow us to extract the circadian
signal from these records with circadian-modulated
noise.
The synthetic luciferin, CycLuc1, offers advantages in terms of signal detection and stability.
CycLuc1 has a lower Km for firefly luciferase than
d-luciferin, and can be used effectively at lower doses
(Evans et al., 2014). The ability of this substrate to be
used at lower concentrations and/or delivered at
slower rates could potentially overcome some of the
limitations imposed by the small volume of minipump reservoirs. Use of CycLuc1 offers the possibility for long-term experiments, with multiple days of
recording providing estimates of circadian period
with increased precision (Cohen et al., 2012).
Another consideration for long-term studies using
implanted osmotic pumps is the aqueous stability of
the luciferin substrate at body temperature. Oxidation
of a luciferin to its respective dehydroluciferin reduces
the luciferin concentration and also introduces a
potent luciferase inhibitor. Substrate oxidation is a
potential confounding variable when using d-luciferin solutions that are maintained for an extended
period at room or body temperature, for example, in
the drinking water or in implanted osmotic pumps.
We observed greater oxidation of d-luciferin than
CycLuc1 in solutions incubated in vitro for 7-14 days
at 37 °C. Oxidation of d-luciferin lowered its relative
performance over time. However, it is possible that
access of oxygen to the solution in implanted pumps
is lower than in the vials we used for the in vitro incubation experiments, limiting the extent of oxidation
that occurs in vivo compared to in vitro.
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We explored several different analysis methods for
assessing the strength of the rhythmic signal in the in
vivo bioluminescence data. The SNR can be useful for
measuring improvements in reducing the high-frequency noise to create a clearer circadian signal, as
can the circadian energy measure. These two measures provide evidence toward whether the period
and phase can be reliably estimated, but are not direct
tests of rhythmicity. Similarly, the Bayesian statistical
analysis provides a measure of how reliable the
period estimate is, but is not a rhythmicity test.
Finding an effective rhythmicity test proved to be
challenging, due to the correlated nature of the highfrequency noise which caused some tests to give spurious results. The two statistical tests that appeared to
work most reliably were JTK_CYCLE and LombScargle, as implemented in MetaCycle (Wu et al.,
2016), using 90-min bins to avoid the problematic
effects of the high-frequency noise. The general conclusion from the various methods is that the in vivo
methods are generating data with clear circadian
rhythms for which period and phase can be estimated
with reasonable precision, analogous to that for other
data with a similar number of cycles.
Our DWT peak results from mice with pumps
(Tables 1 and 2) suggested a possible sex difference
in the timing of the measured rhythms, yet our sample size did not allow firm conclusions. To explore
potential DWT bioluminescence peak differences
between whole-body male and female mice expressing PER2::LUC, we applied our DWT analysis on a
combined dataset including the osmotic minipump
treatments from black C57BL/6 mice presented in
this study (Table 1), and a group of controls from
another recently published paper (van der Vinne
et al., 2020) that studied metabolic consequences and
PER2::LUC bioluminescence in mice lacking a
functional central clock (Vgat-Cre+ Bmal1fl/f, experimental group). The control animals from this study
(No Cre Bmal1fl/f Per2LucSV/+) are similar to the
Per2LucSV/+ animals used in this study. Bioluminescence
data were obtained in our lab using the same equipment and methods presented in this article, with
CycLuc1 substrate delivered at a 0.25-uL/h rate in
14-day pumps. The DWT peak analysis (Figure 9)
showed more variation in DWT peak times in males
(Figure 9b) than females (Figure 9a). We did not apply
statistical analyses since this dataset contained animals from three separate studies, but combining our
studies (Tables 1 and 2) with these previously published data strongly suggests a sex difference is replicable (see Figure 9; color code indicates source
dataset).
We were not able to find any studies describing
sex differences in whole-body PER2::LUC bioluminescence. Our IVIS imaging studies indicate the
kidneys are a major source of bioluminescence, and

Figure 9. PER2::LUC rhythms recorded in vivo from female
(a) and male (b) mice. Abbreviation: DWT = discrete wavelet
transform. Plots show DWT peaks near day 2 mark. 0 = midnight; mice came from a colony room with lights-on 0600-1800 h.
Shaded gray area indicates lights-off in the colony room. DWT
peak marker times for data from mice with osmotic minipumps.
Circles in darker royal blue = 7-day pump, circles in royal blue
= 14-day pumps, circles in dark orchid = albino mPer2Luc/Luc mice
with 14-day pumps, circles in light blue = mPer2LucSV/+ controls
No Cre Bmal1fl/fl Per2LucSV/+ from our previous study (van der
Vinne et al., 2020).

their dorsal location would presumably afford easy
detection of light. The kidneys are likely a (and perhaps the) major contributor to the bioluminescence
signal detected in ambulatory mice. We thus predict that the kidney might show earlier phase of
PER2::LUC bioluminescence in females than in
males. Some sex differences in results from in vitro
bioluminescence of explant tissues have been studied. Amplitude of the PER2::LUC rhythm in the
adrenal and liver is higher in male mice (Kuljis et al.,
2013; Kloehn et al., 2016), and phase of liver and
adrenal rhythms was phase advanced in male mice
(Kuljis et al., 2013). In vitro retinal PER2::LUC oscillations show no sex-dependent effects on amplitude,
period, phase, or rhythmic power (Calligaro et al.,
2020). Sex differences in sleep and circadian variables may play an important role in application of
circadian research on negative health impact of circadian disruption (Boivin et al., 2016; Yan and Silver,
2016; Qian et al., 2019).
Limitations
We have discovered several methodological concerns. Due to the impact of room temperature fluctuations on PMT noise (see Figure 1), our technical
approach requires either carefully controlled room
temperature or (ideally) a method for correction
of temperature-related noise on the PMTs. The
LumiCycle In Vivo (Actimetrics) solves this problem by collecting dark counts regularly and subtracting those measures.
We initially attempted to study mice with E-mitter
implantable telemetry probes (Starr Life Sciences) to
monitor rhythms in body temperature simultaneously with bioluminescence. Unfortunately, when
implanted in a mouse housed in a LumiCycle In Vivo
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unit, the telemetry probes created electronic noise that
appeared as additional PMT signal, especially when
the mouse showed high levels of locomotor activity.
We confirmed this conjecture by detecting rhythmic
“bioluminescence” from a mouse with an implanted
telemetry probe, but with no substrate delivered by
pump or drinking water (data not shown). A different
telemetry system might offer the ability to monitor
body temperature and other rhythms.
While the body temperature probes could not be
used as intended, their presence in animals recovering from the subsequent osmotic pump implant
surgery provided insight into the prolonged effects
of general anesthesia in our mice. During recovery
from surgery, we noted that the circadian rhythm in
body temperature was disrupted for 1-2 days. Based
on these results, we allowed 3 days for colony room
recovery after osmotic pump implantation surgery
in the studies reported here. Alterations in the circadian rhythms in body temperature might interfere
with the hypothesized role of body temperature
rhythms to synchronize rhythms in gene expression
in peripheral tissues (Brown et al., 2002; Buhr et al.,
2010; Schibler et al., 2015). The 3-day recovery
period is a significant portion of the period of pump
life from the 7 day, emphasizing the need to find
alternative routes of administration or substrates
that can be more concentrated to accommodate the
fixed minipump volume, thus allowing longer studies. Our use of drinking water to deliver d-luciferin
allows us to avoid the use of anesthesia and surgery, thus avoiding these potential effects on body
temperature rhythms, but may introduce another
source of variability due to uneven intake of substrate over the day.
Cycles in skin pigmentation and hair regrowth
after shaving of pigmented animals can interfere with
bioluminescence imaging (Curtis et al., 2011) and
should be considered when planning long-term data
collection. At the time of shaving, we noted variations in skin color and texture. Some animals exhibited a mottled skin color on both back and abdomen,
with irregular patches of dark pigmentation. These
variations likely arose from the stage of hair growth
the mouse was in at the time of shaving, which does
not take place uniformly across the animal but rather
occurs in waves (Plikus and Chuong, 2008). In some
cases, hair removal itself can cause more rapid hair
regrowth, or the animal may have already been in an
active stage of the hair regrowth cycle (Li et al., 2017).
Future studies to address this may include crossing
transgenes onto an albino background as we have
done here to avoid the pigmentation and avoid the
need for shaving. A hairless mouse might provide
optimal background (Collaco and Geusz, 2003; Izumi
et al., 2017) although hairless mice might still have

skin pigmentation and can show other alterations in
their phenotype (Hoshino et al., 2017). Moreover,
there are sex differences in the optical properties of
murine skin to be considered in experimental design.
Males show an increase in reflectance and scattering
of the bioluminescent signal due to their generally
thicker dermis (Calabro et al., 2011). Consequently,
careful consideration of timing of shaving as well as
hair regrowth patterns must be taken to ensure optimal bioluminescence recordings. As described, the
variability of pigmentation and hair regrowth patterns might be very limiting when recording from a
tissue-specific area. Both albino and hairless phenotypes arise from recessive alleles; generating reporter
mice with either albino coat or hairlessness requires
at least 2 generations of breeding and might preclude
generating more complicated genetic combinations
(Konger et al., 2016).
Our current results suggest that administration of
substrate in the drinking water can offer a noninvasive and temporally unlimited method for substrate
delivery, at the cost of increased and circadian-modulated noise due to the sporadic dosing. Depending on
the experimental goals and the timing of reporter
expression relative to the drinking behavior rhythm,
this method may be more or less desirable. Pump
delivery allows continuous dosing for multiple
weeks, but brings questions of substrate stability,
given long-term holding substrate at body temperature and introduces the constraint of limited pump
volume.
Future Directions
We anticipate further developments that will continue to optimize this approach for study of the circadian system. We look forward to studies of mice with
various bioluminescent reporters, other synthetic
substrates, and varied delivery methods. It is key to
develop tissue-specific circadian reporters, and substrates may then need to be developed with each target tissue in mind. Further innovation is possible as
this method expands. We did not test other PMTs
available but innovations here might allow better
detection of signals. Note that although firefly luciferase emits green light at room temperature, this
emission is red-shifted at 37 °C and further redshifted by depth-dependent spectral differences in
transmission through the body (Zhao et al., 2005).
PMTs with increased sensitivity at long wavelengths
may thus be desirable. We expect that further optimization of these methods is possible, but here we
demonstrate a method that reliably detects circadian
rhythms in bioluminescence from the mPer2Luc
mouse.
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